Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study-Reference-Cited by-同舟云学术

Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study

Published:2015-02-27 Issue:2 Volume:5 Page:193-197
ISSN:2048-8726
Container-title:European Heart Journal: Acute Cardiovascular Care
language:en
Short-container-title:European Heart Journal: Acute Cardiovascular Care

Author:

Juliard Jean-Michel¹,Golmard Jean-Louis²,Feldman Laurent J¹,Himbert Dominique¹,Nejjari Mohammed¹,Ducrocq Gregory¹,Sorbets Emmanuel¹,Garbarz Eric¹,Aubry Pierre¹,Duchatelle Valérie¹,Vahanian Alec¹,Steg Ph.Gabriel¹³

Affiliation:

1. Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Université Paris-Diderot, Sorbonne Paris-Cité, INSERM U-1148, Paris, France

2. Biostatistics Department, AP-HP, Hôpital Pitié Salpétrière, Paris, France

3. NHLI Imperial College, ICMS Royal Brompton Hospital, London, UK

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2048872615574108

Reference9 articles.

1. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial